Ruby Lieshout
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Liver physiology and pathology 5
- Liver Diseases and Immunity 3
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Surgery 9
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Tissue Engineering and Regenerative Medicine 3
- Pediatric Hepatobiliary Diseases and Treatments 1
- Co-authors
- Luc J. W. van der Laan (11 shared papers)Monique M. A. Verstegen (11 shared papers)Jorke Willemse (3 shared papers)Guoying Zhou (2 shared papers)Dave Sprengers (3 shared papers)Jaap Kwekkeboom (3 shared papers)Maikel Petrus Peppelenbosch (4 shared papers)Martin E. van Royen (2 shared papers)
- Journals
- Cells (2 papers)Clinical and Translational Medicine (1 paper)Communications Biology (1 paper)Nature Medicine (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- NetherlandsGermanySpain
In The Last Decade
Ruby Lieshout
14 papers receiving 1.8k citations
Ruby Lieshout's Hit Papers
Peers
Comparison fields: 5 of 80
- Hepatology 365
- Oncology 646
- Biomedical Engineering 574
- Cancer Research 124
- Surgery 329
Countries citing papers authored by Ruby Lieshout
This map shows the geographic impact of Ruby Lieshout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Lieshout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Lieshout more than expected).
Fields of papers citing papers by Ruby Lieshout
This network shows the impact of papers produced by Ruby Lieshout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Lieshout. The network helps show where Ruby Lieshout may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby Lieshout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human primary liver cancer–derived organoid cultures for disease modeling and drug screening Hit paper breakdown → | 2017 | 1175 |
| 2 | 2020 | 169 | |
| 3 | 2019 | 113 | |
| 4 | 2020 | 93 | |
| 5 | 2022 | 84 | |
| 6 | 2022 | 41 | |
| 7 | 2017 | 39 | |
| 8 | 2019 | 31 | |
| 9 | 2021 | 31 | |
| 10 | 2022 | 14 | |
| 11 | 2022 | 13 | |
| 12 | 2021 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2020 | 1 |
About Ruby Lieshout
Ruby Lieshout is a scholar working on Hepatology, Surgery, Oncology, Cancer Research and Biomedical Engineering, having authored 14 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Liver physiology and pathology (5 papers), Cancer Cells and Metastasis (3 papers), Liver Diseases and Immunity (3 papers), Tissue Engineering and Regenerative Medicine (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Mitochondrial Function and Pathology (1 paper) and Pediatric Hepatobiliary Diseases and Treatments (1 paper). The work is most often cited by research in Hepatology (365 citations), Oncology (646 citations), Biomedical Engineering (574 citations), Cancer Research (124 citations) and Surgery (329 citations). Ruby Lieshout has collaborated with scholars based in Netherlands, Germany and Spain. Frequent co-authors include Luc J. W. van der Laan, Monique M. A. Verstegen, Jorke Willemse, Guoying Zhou, Dave Sprengers, Jaap Kwekkeboom, Maikel Petrus Peppelenbosch, Martin E. van Royen, Gilles S. van Tienderen and Wanlu Cao. Their work appears in journals such as Cells, Clinical and Translational Medicine, Communications Biology, Nature Medicine and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.